Literature DB >> 24012173

Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study.

Bouwe P Krijthe1, Jan Heeringa, Jan A Kors, Albert Hofman, Oscar H Franco, Jacqueline C M Witteman, Bruno H Stricker.   

Abstract

BACKGROUND: Atrial fibrillation is the most common sustained arrhythmia in the elderly. Serum potassium is associated with ventricular arrhythmias and cardiac arrest. Little is known about the association of serum potassium with atrial fibrillation. The objective of this study was to investigate the association of serum potassium and the risk of atrial fibrillation in a population based setting.
METHODS: The study was performed within the prospective population-based Rotterdam Study. The study population consisted of 4059 participants without atrial fibrillation at baseline for whom baseline levels of serum potassium were measured. Atrial fibrillation was ascertained from centre visit ECG assessments as well as medical records.
RESULTS: During a mean follow up of 11.8 years (SD=5.2 yr), 474 participants developed atrial fibrillation. Participants with hypokalemia (<3.5 mmol/l) had a higher risk of atrial fibrillation (HR: 1.63, 95%CI: 1.03-2.56) than those with normokalemia (3.5-5.0 mmol/l). This association was independent of age, sex, serum magnesium, and other potential confounders. Especially in participants with a history of myocardial infarction, those with hypokalemia had a higher risk of atrial fibrillation than those with normokalemia (HR: 3.81, 95%-CI: 1.51-9.61).
CONCLUSIONS: In this study low serum levels of potassium were associated with a higher risk of atrial fibrillation.
© 2013.

Entities:  

Keywords:  Atrial fibrillation; Epidemiology; Serum potassium

Mesh:

Substances:

Year:  2013        PMID: 24012173     DOI: 10.1016/j.ijcard.2013.08.048

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  29 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

Review 2.  Atrial Fibrillation in the ICU.

Authors:  Nicholas A Bosch; Jonathan Cimini; Allan J Walkey
Journal:  Chest       Date:  2018-04-06       Impact factor: 9.410

3.  Non-antiarrhythmic interventions in new onset and paroxysmal sepsis-related atrial fibrillation.

Authors:  Antoine Vieillard-Baron; John Boyd
Journal:  Intensive Care Med       Date:  2017-11-07       Impact factor: 17.440

4.  Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis.

Authors:  Timothy S Lancaster; Matthew R Schill; Jason W Greenberg; Marc R Moon; Richard B Schuessler; Ralph J Damiano; Spencer J Melby
Journal:  Ann Thorac Surg       Date:  2016-09-02       Impact factor: 4.330

Review 5.  Optimizing atrial fibrillation management: from ICU and beyond.

Authors:  Allan J Walkey; D Kyle Hogarth; Gregory Y H Lip
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

6.  Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.

Authors:  Allan J Collins; Bertram Pitt; Nancy Reaven; Susan Funk; Karen McGaughey; Daniel Wilson; David A Bushinsky
Journal:  Am J Nephrol       Date:  2017-09-02       Impact factor: 3.754

7.  Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis.

Authors:  Eduardo Verde; Armando Pérez de Prado; Juan M López-Gómez; Borja Quiroga; Marian Goicoechea; Ana García-Prieto; Esther Torres; Javier Reque; José Luño
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-03       Impact factor: 8.237

8.  Transient outward K+ current can strongly modulate action potential duration and initiate alternans in the human atrium.

Authors:  Haibo Ni; Henggui Zhang; Eleonora Grandi; Sanjiv M Narayan; Wayne R Giles
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-12-21       Impact factor: 4.733

9.  Circulating electrolytes and the prevalence of atrial fibrillation and supraventricular ectopy: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Mary R Rooney; Lin Y Chen; Faye L Norby; Amy K Saenger; Elsayed Z Soliman; Wesley T O'Neal; Katie C Hootman; Elizabeth Selvin; Pamela L Lutsey
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-03-27       Impact factor: 4.222

10.  Immediate and Delayed Response of Simulated Human Atrial Myocytes to Clinically-Relevant Hypokalemia.

Authors:  Michael Clerx; Gary R Mirams; Albert J Rogers; Sanjiv M Narayan; Wayne R Giles
Journal:  Front Physiol       Date:  2021-05-26       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.